Celularity Analyst Ratings
Celularity Analyst Ratings
While ratings are subjective and will change, the latest Celularity (CELU) rating was a maintained with a price target of $15.00 to $2.50. The current price Celularity (CELU) is trading at is $1.05, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/30/2023 | 138.1% | HC Wainwright & Co. | $15 → $2.5 | Maintains | Buy |
| 12/22/2022 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 09/12/2022 | 376.19% | Morgan Stanley | $8 → $5 | Maintains | Equal-Weight |
| 08/25/2022 | 1328.57% | Alliance Global Partners | → $15 | Initiates Coverage On | → Buy |
| 08/23/2022 | 471.43% | Truist Securities | $10 → $6 | Maintains | Hold |
| 06/22/2022 | 1328.57% | HC Wainwright & Co. | → $15 | Initiates Coverage On | → Buy |
| 04/06/2022 | — | Truist Securities | Downgrades | Buy → Hold | |
| 01/28/2022 | 757.14% | Oppenheimer | → $9 | Initiates Coverage On | → Outperform |
| 11/24/2021 | 757.14% | Morgan Stanley | → $9 | Initiates Coverage On | → Equal-Weight |
| 10/19/2021 | 1042.86% | Truist Securities | → $12 | Initiates Coverage On | → Buy |
| 日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
|---|---|---|---|---|---|
| 01/30/2023 | 138.1% | HC 溫賴特 & 有限公司. | 一百五十元 → 2.5 美元 | 維護 | 購買 |
| 12/22/2022 | — | 奧本海默 | 降級 | 跑贏大市 → 執行 | |
| 2022 年 12 月 9 日 | 376.19% | 摩根士丹利 | 8 美元 → 5 美元 | 維護 | 同等重量 |
| 08/25/2022 | 1328.57% | 聯盟全球夥伴 | → 15 美元 | 啟動覆蓋範圍 | → 購買 |
| 08/23/2022 | 471.43% | 真理證券 | 十美元 → 6 美元 | 維護 | 保持 |
| 2022 年 06 月 22 日 | 1328.57% | HC 溫賴特 & 有限公司. | → 15 美元 | 啟動覆蓋範圍 | → 購買 |
| 04/06/2022 | — | 真理證券 | 降級 | 購買 → 持有 | |
| 01/28/2022 | 757.14% | 奧本海默 | → 9 美元 | 啟動覆蓋範圍 | → 跑贏大市 |
| 11/24/2021 | 757.14% | 摩根士丹利 | → 9 美元 | 啟動覆蓋範圍 | → 同等重量 |
| 10/19/2021 | 1042.86% | 真理證券 | → 十二美元 | 啟動覆蓋範圍 | → 購買 |
What is the target price for Celularity (CELU)?
天然 (CELU) 的目標價格是多少？
The latest price target for Celularity (NASDAQ: CELU) was reported by HC Wainwright & Co. on January 30, 2023. The analyst firm set a price target for $2.50 expecting CELU to rise to within 12 months (a possible 138.10% upside). 7 analyst firms have reported ratings in the last year.
韋萊特有限公司於 2023 年 1 月 30 日報導了奇魯達（納斯達克股票代碼：CELU）的最新價格目標。該分析師公司設定了 2.50 美元的價格目標，預計 CELU 將在 12 個月內上升至（可能上漲 138.10％）。去年有 7 家分析師公司報告了評級。
What is the most recent analyst rating for Celularity (CELU)?
奇魯達 (CELU) 的最新分析師評級為何？
The latest analyst rating for Celularity (NASDAQ: CELU) was provided by HC Wainwright & Co., and Celularity maintained their buy rating.
奇魯達（納斯達克股份代號：CELU）的最新分析師評級由 HC 溫賴特公司提供，而奇魯達維持其買入評級。
When is the next analyst rating going to be posted or updated for Celularity (CELU)?
什麼時候將公佈或更新天然 (CELU) 的下一個分析師評級？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Celularity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Celularity was filed on January 30, 2023 so you should expect the next rating to be made available sometime around January 30, 2024.
分析師在進行了廣泛的研究後獲得了股票評級，其中包括通過公共財務報表，與 Celularity 的高管和客戶交談以及收聽盈利電話會議。大多數分析師每三個月這樣做一次，因此您應該每年每家公司獲得 4 個評級。天然的最後一個評分在 2023 年 1 月 30 日提交，因此您應該期望下一個評分將在 2024 年 1 月 30 日左右的某個時候提供。
Is the Analyst Rating Celularity (CELU) correct?
分析師評等精度 (CELU) 是否正確？
While ratings are subjective and will change, the latest Celularity (CELU) rating was a maintained with a price target of $15.00 to $2.50. The current price Celularity (CELU) is trading at is $1.05, which is out of the analyst's predicted range.
儘管評分是主觀的並且會發生變化，但最新的 CELU 評級維持在 15.00 美元至 2.50 美元的目標價格。當前價格 CELU（CELU）的交易價格為 1.05 美元，超出了分析師的預測範圍。
譯文內容由第三人軟體翻譯。
